Private Equity Profile
In the last 3 years, Morgenthaler Private Equity has acquired 3 companies. It has also invested in 2 others.
Morgenthaler Private Equity’s most common sectors for investment are life science (19%) and medical products (13%). The Firm’s most common investment types include venture (54%) and recapitalization (21%). In total, Morgenthaler Private Equity has invested in 18 US states and 4 different countries. Its largest (disclosed) acquisition occurred in 2006 when it acquired OREXIGEN Therapeutics for $30M.
In the last 3 years, Morgenthaler Private Equity has exited 6 companies. The Firm’s most common exit type is trade sale (46%). Morgenthaler Private Equity’s largest (disclosed) exit occurred in 2019 when it sold Promedior for $1.4B.
Join Mergr to view Morgenthaler Private Equity’s full profile and discover more mega-sized private equity firms just like it.
M&A Total Activity137
- M&A Buy Activity82
- M&A Sell Activity55
- Total Sectors Invested 20
- Total Countries Invested 4
- M&A Buy/Sell Connections 67
- M&A Advisors 14